Skip to Content
Merck
CN
  • Identification of two novel ALS2 mutations in infantile-onset ascending hereditary spastic paraplegia.

Identification of two novel ALS2 mutations in infantile-onset ascending hereditary spastic paraplegia.

Amyotrophic lateral sclerosis & frontotemporal degeneration (2016-01-12)
Shakeela Daud, Naseebullah Kakar, Ingrid Goebel, Abu Saeed Hashmi, Tahir Yaqub, Gudrun Nürnberg, Peter Nürnberg, Deborah J Morris-Rosendahl, Muhammad Wasim, Alexander E Volk, Christian Kubisch, Jamil Ahmad, Guntram Borck
ABSTRACT

Biallelic mutations of ALS2 cause a clinical spectrum of overlapping autosomal recessive neurodegenerative disorders: infantile-onset ascending hereditary spastic paralysis (IAHSP), juvenile primary lateral sclerosis (JPLS), and juvenile amyotrophic lateral sclerosis (ALS2). We report on eleven individuals affected with IAHSP from two consanguineous Pakistani families. A combination of linkage analysis with homozygosity mapping and targeted sequencing identified two novel ALS2 mutations, a c.194T > C (p.Phe65Ser) missense substitution located in the first RCC-like domain of ALS2/alsin and a c.2998delA (p.Ile1000*) nonsense mutation. This study of extended families including a total of eleven affected individuals suggests that a given ALS2 mutation may lead to a phenotype with remarkable intrafamilial clinical homogeneity.